Vision

BOSTON — Results from the ARMOR study indicate that about 70% of Staphylococcus organisms in the eye are resistant to commonly used antibiotics.

Short-term peripheral myopic defocus significantly inhibited axial elongation in adults, according to a study published in Scientific Reports.

BOSTON – The pH of the recently approved Vuity from Allergan, an Abbvie company, improves the drug’s availability and translates to faster pupil size reduction, according to a presentation here at the American Academy of Optometry annual meeting.

EyeCare Partners announced it has successfully merged with CEI Vision.

BOSTON – Vivid Vision software is indicated for treating convergence insufficiency, stereo depth perception, amblyopia and strabismus either in the clinic or at home, according to a presentation here at the American Academy of Optometry meeting.

BOSTON — The new FMAT1 measures tonometry, ophthalmodynamometry, tonography and ocular pulse amplitude, helping clinicians better manage glaucoma, J. James Thimons, OD, said at the American Academy of Optometry annual meeting.

BOSTON – Designate an in-house dry eye expert to present details and pricing to patients after making the treatment recommendation, Carly Rose, OD, said here at the American Academy of Optometry.

BOSTON – Eschenbach Optik of America introduced the Smartlux Digital, designed to help patients with age-related macular degeneration and diabetic retinopathy with daily living tasks, here at the American Academy of Optometry annual meeting.

The vision correction industry produced $10.7 billion in sales revenue in the second quarter of 2021, a marked increase from a year ago.

Legislation signed by New York Governor Kathy Hochul Oct. 25 will allow optometrists in the state to prescribe oral medications.